JPH10130191A - 2-acetyl carboxylic acid ester derivative and production of 2-ketone compounds from the same - Google Patents

2-acetyl carboxylic acid ester derivative and production of 2-ketone compounds from the same

Info

Publication number
JPH10130191A
JPH10130191A JP22779897A JP22779897A JPH10130191A JP H10130191 A JPH10130191 A JP H10130191A JP 22779897 A JP22779897 A JP 22779897A JP 22779897 A JP22779897 A JP 22779897A JP H10130191 A JPH10130191 A JP H10130191A
Authority
JP
Japan
Prior art keywords
carboxylic acid
acid ester
acetyl
skin
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP22779897A
Other languages
Japanese (ja)
Inventor
Taketoshi Fujimori
健敏 藤森
Akiyo Kameyama
明代 亀山
Akira Yamamuro
朗 山室
Yoshiaki Fujikura
芳明 藤倉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP22779897A priority Critical patent/JPH10130191A/en
Publication of JPH10130191A publication Critical patent/JPH10130191A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a new acetyl carboxylic acid ester derivative useful as an intermediate for synthesizing amine derivatives expressing remarkable actions on the prevention of skin aging, such as the improvement of conification, the prevention and improvement of the pigmentation of skin, by reacting a halogenated alcohol derivative with a 2-acetyl carboxylic acid ester. SOLUTION: A 2-acetyl carboxylic acid ester derivative of formula III [R<1> is H, benzyl; R<2> is a lower alkyl; (n) is an integer of 8-12], e.g. 2-acetyl-12- hydroxydodecanoic acid methyl ester. The compound of formula III is obtained by reacting one mole of a halogenated alcohol derivative of formula I (X is chlorine, bromine or iodine) with 1-10 moles of a 2-acetyl carboxylic acid ester of formula II in the presence of a base such as sodium hydroxide or sodium methoxide. The reaction is carried out in a solvent such as dimethylformamide, toluene or methanol at a reacting temperature of 50-150 deg.C in the presence of a phase transfer catalyst such as n-tetrabutyl ammonium chloride. The compound of formula III is hydrolyzed and subsequently decarbonated to produce a 2-ketone compound.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、優れた老化防止効
果を有するアミン誘導体の合成中間体として有用な2−
アセチルカルボン酸エステル誘導体及びこれを用いた2
−ケトン類の製造法に関する。
[0001] The present invention relates to a 2- (2-amino) amine derivative useful as a synthetic intermediate having an excellent anti-aging effect.
Acetyl carboxylic acid ester derivative and 2 using the same
-It relates to a process for producing ketones.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】皮膚の
最外層である表皮は、生体からの水分や種々の成分の損
失を防ぎ、生体の恒常的維持を司っている。また、外界
からの物理的・化学的刺激(温度、湿度など)さらに
は、種々の細菌から身体を保護するバリア能も有してお
り、その生理的機能は生体の生命活動に大変重要であ
る。この表皮を形成しているケラチノサイトは、細胞増
殖と角化(分化)をバランス良く行なうことで上述した
生理機能を有する健全な表皮を形成する。
2. Description of the Related Art The epidermis, which is the outermost layer of the skin, prevents loss of water and various components from the living body and controls the homeostasis of the living body. In addition, it has a barrier function to protect the body from physical and chemical stimuli (temperature, humidity, etc.) from the outside world, as well as various bacteria, and its physiological functions are very important for the vital activities of living organisms. . The keratinocytes forming the epidermis form healthy epidermis having the above-mentioned physiological functions by performing cell proliferation and keratinization (differentiation) in a well-balanced manner.

【0003】しかしながら、外環境からの過剰な刺激
(紫外線など)や生理機能の変動(加齢に伴う皮膚老化
や疾患など)といった生体に作用する体内外の因子によ
り、この細胞増殖と角化のバランスが崩れると健全な表
皮形成が妨げられる。特に、顔や手など日常的に紫外線
等の刺激に曝されている部位は、多くの場合、増殖過多
及び角化が不十分な状態となっている。そのため、表皮
肥厚や不全角化が誘起され、その結果、乾性肌又は脂性
肌、フケ症等の様々な尋常性の皮膚トラブルを生じるこ
とになる。さらに角栓形成によりニキビの発症、メラニ
ン代謝の遅延により色素沈着等の様々な皮膚トラブルを
生じると考えられる。このような皮膚のトラブルを改善
し、健常な皮膚を維持するためには、起因物質や事象を
排除あるいは減少させるか、ある種の成分を添加、塗布
する方法が考えられる。従来、皮膚のトラブルを予防、
改善する主たる方法として、保湿能の低下等に対しては
合成あるいは天然の保湿成分を塗布することにより皮膚
の乾燥を防ぎ皮膚の保湿能を高める手法や血行促進剤の
塗布による皮膚の血行促進により改善する試みがなされ
てきた。
However, factors such as excessive stimulation from the external environment (such as ultraviolet rays) and changes in physiological functions (such as age-related skin aging and diseases) that act on the living body and the body cause this cell proliferation and keratinization. A loss of balance prevents healthy epidermis formation. In particular, sites that are routinely exposed to stimuli such as ultraviolet rays, such as the face and hands, are often in a state of excessive proliferation and insufficient keratinization. As a result, epidermal thickening and parakeratosis are induced, and as a result, various vulnerable skin troubles such as dry skin or oily skin and dandruff are caused. Further, it is considered that various skin troubles such as pigmentation and the like occur due to the onset of acne due to the formation of keratosis and the delay of melanin metabolism. In order to improve such skin troubles and maintain healthy skin, it is conceivable to eliminate or reduce the causative substances and events, or to add and apply certain components. Conventionally, prevent skin problems,
The main method of improvement is to apply a synthetic or natural moisturizing component to prevent the skin from drying out and increase the moisturizing ability of the skin by applying a moisturizing component or to promote the blood circulation of the skin by applying a blood circulation promoting agent. Attempts have been made to improve.

【0004】また、シミ、ソバカス及び日焼け後の肌へ
の色素沈着は、加齢に伴う皮膚の老化により発生、増加
し、しかも消失しにくいため、中高年齢層にとって悩み
となっている。これらの色素沈着症の発生機構は未だ明
確にはされていないが、太陽光線、特に紫外線やメラノ
サイト刺激ホルモンなどの作用により表皮メラノサイト
でのメラニン合成機構が亢進したためと考えられ、従
来、このような後天的色素(すなわちメラニン)沈着部
を正常皮膚色まで回復させるために、例えばビタミンC
(L−アスコルビン酸)誘導体やイソフラボン誘導体
(特開昭58−225004号公報)、p−ヒドロキシ
桂皮酸誘導体(特開昭59−196813号公報)等に
より改善する試みがなされてきた。
[0004] In addition, pigmentation on spots, freckles, and skin after sunburn occurs, increases, and hardly disappears due to aging of the skin with aging, which is a problem for middle-aged and elderly people. Although the mechanism of the occurrence of these pigmentation diseases has not yet been clarified, it is thought that the mechanism of melanin synthesis in epidermal melanocytes was enhanced by the action of sunlight, particularly ultraviolet rays and melanocyte stimulating hormones. To restore the acquired pigment (ie melanin) deposits to normal skin color, for example, vitamin C
Attempts have been made to improve with (L-ascorbic acid) derivatives, isoflavone derivatives (JP-A-58-225004), p-hydroxycinnamic acid derivatives (JP-A-59-196813) and the like.

【0005】しかしながら、前記の方法は種々の皮膚ト
ラブルの予防、改善における有効性、効果の持続性、及
び薬剤の安定性・安全性等の点で、種々の問題を有して
いる。すなわち、これらの方法は、一般的に表皮、特に
角質表面の水分を補給するもの、又は保湿成分の一部を
補うものであることから、その効果効能は一時的なもの
であり、永続的かつ根本的な皮膚の改善は期待できない
ものであった。また、色素沈着に対しても実質的な色素
沈着予防・改善効果に優れた物質はいまだ知られていな
いのが現状である。従って皮膚の不全角化、表皮肥厚、
脂質代謝異常等に対し顕著な抑制効果を有し、皮膚の色
素沈着予防・改善効果を有する皮膚老化防止効果及び角
化異常に起因する皮膚トラブルの改善効果に優れる物質
の開発が望まれていた。
[0005] However, the above methods have various problems in terms of the effectiveness in preventing and improving various skin troubles, the persistence of the effects, and the stability and safety of drugs. That is, since these methods generally rehydrate the epidermis, especially the surface of the keratin, or supplement a part of the moisturizing component, the effect is temporary, permanent and permanent. Fundamental skin improvement could not be expected. At present, there is no known substance which has a substantial effect of preventing or improving pigmentation. Therefore, skin parakeratosis, epidermal thickening,
It has been desired to develop a substance that has a remarkable inhibitory effect on lipid metabolism abnormalities and the like, has an effect of preventing skin aging having an effect of preventing and improving pigmentation of the skin, and an effect of improving skin troubles caused by abnormal keratinization. .

【0006】本発明者らは、特定のアミン誘導体が角化
改善、皮膚の色素沈着予防・改善等の皮膚老化防止に顕
著な作用を示すことを見出し、先に特許出願した(特開
平5−194185号、特開平6−271450号
等)。これらの出願の明細書に開示した化合物のうち、
下記式(A)
The present inventors have found that a specific amine derivative has a remarkable effect on the prevention of skin aging, such as improvement of keratinization and prevention / improvement of skin pigmentation, and have previously filed a patent application (Japanese Patent Application Laid-Open No. 5-205). 194185, JP-A-6-271450, etc.). Of the compounds disclosed in the specifications of these applications,
The following formula (A)

【0007】[0007]

【化3】 Embedded image

【0008】(式中、a及びbは、a+b=11〜1
7、a=4〜10、b=5〜11で、a=7、b=8を
頂点とする分布を有する数を示す。)で表わされるアミ
ン誘導体〔特開平5−194195号公報では化合物
(1g)〕が特に、優れた角化改善、皮膚の色素沈着予
防・改善等の効果を有する。このアミン誘導体(A)
は、牛脂や大豆油等からダイマー酸を製造する際副生物
であるイソステアリン酸を還元して得られるイソステア
リルアルコールを原料に使用しているため、主に主鎖上
の様々な位置にメチル分岐を有する化合物の混合物であ
る。
(Where a and b are a + b = 11-1)
7, a = 4 to 10, b = 5 to 11, and a number having a distribution with a = 7 and b = 8 as vertices. In particular, the amine derivative [compound (1g) in JP-A-5-194195] has excellent effects such as excellent keratinization and prevention / improvement of skin pigmentation. This amine derivative (A)
Uses isostearyl alcohol, which is obtained by reducing isostearic acid, a by-product when producing dimer acid from beef tallow and soybean oil, as a raw material, so methyl branching occurs mainly at various positions on the main chain. Is a mixture of compounds having the formula:

【0009】本発明者らは、このものが混合物でありな
がら、優れた角化改善、皮膚の色素沈着予防・改善等を
有することに着目し、このアミン誘導体(A)中の活性
成分の探索に着手した。その結果、HPLCによる分画
及びGC−MSによる構造決定により、下記の構造を持
つ化合物群(B)に高い角化改善効果があることを見出
した。
The present inventors have paid attention to the fact that, although this is a mixture, it has excellent keratinization, prevention / improvement of skin pigmentation, etc., and searches for the active ingredient in this amine derivative (A). Embarked on. As a result, it was found that the compound group (B) having the following structure had a high keratinizing effect by fractionation by HPLC and structure determination by GC-MS.

【0010】[0010]

【化4】 Embedded image

【0011】〔上記一般式中、Rb は総炭素数17であ
り、7〜15位の間にメチル基を1つ置換基として有す
るアルキル基を示す〕 上記アミン誘導体(B)は、アミン誘導体(A)中に約
3%しか含有されていない。
[In the above general formula, R b is a total of 17 carbon atoms and represents an alkyl group having one methyl group as a substituent between the 7th and 15th positions.] The amine derivative (B) is an amine derivative (A) contains only about 3%.

【0012】そこで本発明者らは、さらにアミン誘導体
(B)に含まれる個々の化合物を合成・評価すると共
に、様々な周辺化合物を探索した結果、下記一般式
(C)で表わされるアミン誘導体が、極めて優れた角化
改善、皮膚の色素沈着予防・改善効果及び角化異常に起
因する皮膚トラブルの改善効果を有することを見出し
た。
Therefore, the present inventors further synthesized and evaluated individual compounds contained in the amine derivative (B) and searched for various peripheral compounds. As a result, the amine derivative represented by the following general formula (C) was obtained. It has been found to have extremely excellent keratinization improvement, skin pigmentation prevention and improvement effects, and skin troubles caused by abnormal keratinization.

【0013】[0013]

【化5】 Embedded image

【0014】〔式中、R3 は、水素原子又は1もくしは
2以上のヒドロキシ基が置換していてもよい炭素数1〜
3のアルキル基を示し、mは0〜11の整数を示し、n
は8〜12の整数を示す〕
[Wherein R 3 represents a hydrogen atom or a carbon atom which may be substituted by one or more hydroxy groups.
3 represents an alkyl group; m represents an integer of 0 to 11;
Represents an integer of 8 to 12]

【0015】このアミン誘導体(C)は、例えば、次の
反応式(a)に従って製造することができる。
The amine derivative (C) can be produced, for example, according to the following reaction formula (a).

【0016】[0016]

【化6】 Embedded image

【0017】〔式中、R3 、m及びnは前記と同じもの
を示す〕 しかしながら、上記反応において、炭素数8以上のハロ
ゲン化物から調製されるグリニャール試薬とケトンとの
反応は副反応であるアルドール反応が進行し易くなるた
め収率が低いという問題点があった。
Wherein R 3 , m and n are the same as above. However, in the above reaction, the reaction between a Grignard reagent prepared from a halide having 8 or more carbon atoms and a ketone is a side reaction. There is a problem that the yield is low because the aldol reaction proceeds easily.

【0018】従って、本発明の目的は、工業的に有利
に、アミン誘導体(C)を製造する方法及び中間体を提
供することにある。
Accordingly, an object of the present invention is to provide a method and an intermediate for producing an amine derivative (C) which are industrially advantageous.

【0019】[0019]

【課題を解決するための手段】斯かる実情に鑑み本発明
は鋭意研究を行った結果、下記一般式(1)を経由する
次の反応式に従って、アミン誘導体(C)を工業的に有
利に製造できることを見出し本発明を完成した。
Means for Solving the Problems In view of such circumstances, the present invention has made intensive studies and found that the amine derivative (C) can be industrially advantageously produced according to the following reaction formula via the following general formula (1). The present inventors have found that they can be manufactured and completed the present invention.

【0020】[0020]

【化7】 Embedded image

【0021】〔式中、Xは塩素原子、臭素原子又はヨウ
素原子を示し、R1 、R2 、R3 、m及びnは前記と同
じものを示す〕
[In the formula, X represents a chlorine atom, a bromine atom or an iodine atom, and R 1 , R 2 , R 3 , m and n are the same as those described above.]

【0022】すなわち、本発明は、一般式(1)で表わ
される2−アセチルカルボン酸エステル誘導体(1)並
びにこれを加水分解及び脱炭酸することを特徴とする一
般式(2)で表わされる2−ケトン類の製造法を提供す
るものである。
That is, the present invention provides a 2-acetylcarboxylic acid ester derivative (1) represented by the general formula (1) and a compound represented by the general formula (2) characterized by hydrolyzing and decarboxylating the derivative. -To provide a method for producing ketones.

【0023】[0023]

【発明の実施の形態】本発明の2−アセチルカルボン酸
エステル誘導体は、前記一般式(1)で表わされるもの
であり、式中R1 は水素原子又はベンジル基を表わす。
またR2 で示される低級アルキル基としては、メチル
基、エチル基、直鎖又は分岐鎖のプロピル、ブチル、ペ
ンチル及びヘキシル基が挙げられるが、就中、メチル基
又はエチル基が好ましい。また、一般式(1)中のn
は、8〜12の整数であるが、9又は10が特に好まし
い。
BEST MODE FOR CARRYING OUT THE INVENTION The 2-acetylcarboxylic ester derivative of the present invention is represented by the general formula (1), wherein R 1 represents a hydrogen atom or a benzyl group.
Examples of the lower alkyl group represented by R 2 include a methyl group, an ethyl group, a linear or branched propyl, butyl, pentyl, and hexyl group, with a methyl group or an ethyl group being preferred. Further, n in the general formula (1)
Is an integer of 8 to 12, but 9 or 10 is particularly preferred.

【0024】本発明化合物(1)は、例えば、前記一般
式(4)で表わされるハロゲン化アルコール誘導体に、
これに対して1〜10当量の2−アセチルカルボン酸エ
ステル(3)を反応させれば、本発明化合物(1)を得
ることができる。なお、ここで用いる2−アセチルカル
ボン酸エステル(3)は工業原料として容易に入手可能
である。具体的には、化合物(3)に化合物(4)を加
え混合し、溶液とし、これに塩基を加えればよい。ここ
で用いる塩基としては、例えば、水酸化ナトリウム、水
酸化カリウム、炭酸カリウム、水素化ナトリウム、ナト
リウムメトキシド、ナトリウムエトキシド等が挙げら
れ、就中、ナトリウムメトキシド、ナトリウムエトキシ
ド及びこれらのアルコール溶液が好ましい。塩基の使用
量は、ハロゲン化アルコールに対して0.1〜5当量、
特に1〜3当量とすることが好ましい。また、この反応
に用いる溶媒としては、ジメチルホルムアミド、テトラ
ヒドロフラン、1,4−ジオキサン、トルエン、キシレ
ン、メタノール、エタノール、プロパノール等の各種溶
媒を使用することができ、特にジメチルホルムアミド、
メタノール、エタノールが好ましい。この反応の温度
は、0〜150℃、特に50〜150℃とすることが好
ましい。さらに、反応速度を上げるために、n−テトラ
ブチルアンモニウムブロマイド、硫酸水素n−テトラブ
チルアンモニウム、メチル−β−シクロデキストリン等
の相関移動触媒をハロゲン化アルコールに対して1〜2
0重量%用いてもよい。
The compound (1) of the present invention is, for example, a halogenated alcohol derivative represented by the aforementioned general formula (4),
By reacting 1 to 10 equivalents of 2-acetylcarboxylic acid ester (3), compound (1) of the present invention can be obtained. In addition, the 2-acetyl carboxylic acid ester (3) used here can be easily obtained as an industrial raw material. Specifically, compound (4) is added to compound (3), mixed to form a solution, and a base may be added thereto. Examples of the base used herein include sodium hydroxide, potassium hydroxide, potassium carbonate, sodium hydride, sodium methoxide, sodium ethoxide and the like. Among them, sodium methoxide, sodium ethoxide and alcohols thereof Solutions are preferred. The amount of the base used is 0.1 to 5 equivalents to the halogenated alcohol,
In particular, it is preferable to use 1 to 3 equivalents. As the solvent used for this reaction, various solvents such as dimethylformamide, tetrahydrofuran, 1,4-dioxane, toluene, xylene, methanol, ethanol, and propanol can be used. Particularly, dimethylformamide,
Methanol and ethanol are preferred. The temperature of this reaction is preferably 0 to 150 ° C, particularly preferably 50 to 150 ° C. Further, in order to increase the reaction rate, a phase transfer catalyst such as n-tetrabutylammonium bromide, n-tetrabutylammonium hydrogensulfate, methyl-β-cyclodextrin or the like is added to the halogenated alcohol by 1 to 2
0% by weight may be used.

【0025】なお一般式(4)で表わされるω−クロロ
−1−アルカノール、及びω−クロロ−1−ベンジルオ
キシアルカンは、例えば次の方法により製造することが
できる。1,ω−アルカンジオールと塩酸とを、硫酸又
はリン酸、及びキシレン等の溶媒の存在下で反応させ、
ω−クロロ−1−アルカノールを得る。次いでこのω−
クロロ−1−アルカノールとベンジルクロライドとを、
塩基、及びテトラ−n−ブチルアンモニウムブロマイド
の存在下で反応させることにより、ω−クロロ−1−ベ
ンジルオキシアルカンを得ることができる。
The ω-chloro-1-alkanol and ω-chloro-1-benzyloxyalkane represented by the general formula (4) can be produced, for example, by the following method. Reacting 1, ω-alkanediol and hydrochloric acid in the presence of a solvent such as sulfuric acid or phosphoric acid, and xylene,
ω-Chloro-1-alkanol is obtained. Then this ω-
Chloro-1-alkanol and benzyl chloride,
By reacting in the presence of a base and tetra-n-butylammonium bromide, ω-chloro-1-benzyloxyalkane can be obtained.

【0026】本発明化合物(1)を、加水分解及び脱炭
酸することにより、式(2)で表わされる2−ケトン類
を製造することができる。加水分解は塩基又は酸を用い
る一般的な手法によって行うことが可能であり、塩基と
しては水酸化ナトリウム、水酸化カリウム、ナトリウム
メトキシド、ナトリウムエトキシド等が、酸としては硫
酸、塩酸等が例示される。また溶媒としては、水、メタ
ノール、エタノール等を用いることが好ましく、反応温
度は、20〜150℃の範囲とすることが好ましい。ま
た、脱炭酸も常法により行うことが可能であり、例えば
加水分解に塩基を用いた場合は酸を加え、中性〜酸性に
した後、50〜150℃に加熱することによって行うこ
とができる。脱炭酸に用いる酸又は塩基は、加水分解に
用いたものが挙げられる。
By hydrolyzing and decarboxylating the compound (1) of the present invention, 2-ketones represented by the formula (2) can be produced. The hydrolysis can be performed by a general method using a base or an acid. Examples of the base include sodium hydroxide, potassium hydroxide, sodium methoxide, and sodium ethoxide, and examples of the acid include sulfuric acid and hydrochloric acid. Is done. As the solvent, it is preferable to use water, methanol, ethanol, or the like, and the reaction temperature is preferably in the range of 20 to 150 ° C. In addition, decarboxylation can also be carried out by a conventional method. For example, when a base is used for hydrolysis, it can be carried out by adding an acid to make it neutral to acidic, and then heating it to 50 to 150 ° C. . Acids or bases used for decarboxylation include those used for hydrolysis.

【0027】このようにして得られた化合物(2)は、
前記の反応式(b)に従って反応を行えば、皮膚トラブ
ルの改善効果に優れたアミン誘導体(C)を得ることが
できる。
The compound (2) thus obtained is
When the reaction is carried out according to the above reaction formula (b), an amine derivative (C) having an excellent effect of improving skin trouble can be obtained.

【0028】[0028]

【発明の効果】本発明の2−アセチルカルボン酸エステ
ル誘導体(1)をアミン誘導体(C)の合成中間体とし
て用いれば、グリニャール反応において副反応であるア
ルドール反応はほとんど進行することなく、工業的に有
利にアミン誘導体を製造することができる。また、本発
明の方法によれば、容易に2−ケトン類を製造すること
ができる。
Industrial Applicability When the 2-acetylcarboxylic ester derivative (1) of the present invention is used as an intermediate for synthesizing the amine derivative (C), the aldol reaction which is a side reaction in the Grignard reaction hardly progresses, and industrial An amine derivative can be advantageously produced. According to the method of the present invention, 2-ketones can be easily produced.

【0029】[0029]

【実施例】以下、実施例を挙げて本発明をさらに詳細に
説明するが、本発明は、これらに限定されるものではな
い。
The present invention will be described below in more detail with reference to examples, but the present invention is not limited to these examples.

【0030】実施例1〜3 2−アセチル−12−ヒ
ドロキシドデカン酸メチル(1−1,2−1,3−1)
の製造
Examples 1 to 3 Methyl 2-acetyl-12-hydroxydodecanoate (1-1,2-1,3-1)
Manufacturing of

【0031】[0031]

【化8】 Embedded image

【0032】実施例1 還流冷却管及び10ml−滴下ロートを備えた50ml−2
口フラスコに窒素雰囲気下、アセト酢酸メチル(1−
3)1.02g(8.8mmol)、10−ブロモ−1−デ
カノール(1−4)1.03g(4.3mmol)、ジメチ
ルホルムアミド3mlを入れ、氷冷下で20分間攪拌し、
これに28%ナトリウムメトキシドのメタノール溶液
1.67g(8.8mmol)を滴下した。60℃で6時間
攪拌した後、放冷し、水20mlを加え、クロロホルムで
抽出を行ったのち、無水硫酸マグネシウムで乾燥し、濾
別後、減圧濃縮して得られる粗生物をシリカゲルクロマ
トグラフィーにて精製して、標記化合物(1−1)0.
68g(収率58%)を得た。
Example 1 50 ml-2 equipped with a reflux condenser and a 10 ml-dropping funnel
Methyl acetoacetate (1-
3) 1.02 g (8.8 mmol), 1.03 g (4.3 mmol) of 10-bromo-1-decanol (1-4) and 3 ml of dimethylformamide were added, and the mixture was stirred under ice cooling for 20 minutes.
To this, 1.67 g (8.8 mmol) of a methanol solution of 28% sodium methoxide was added dropwise. After stirring at 60 ° C. for 6 hours, the mixture was left to cool, added with 20 ml of water, extracted with chloroform, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to obtain a crude product which was subjected to silica gel chromatography. And purified to give the title compound (1-1).
68 g (58% yield) were obtained.

【0033】実施例2 還流冷却管及び10ml−滴下ロートを備えた30ml−2
口フラスコに窒素雰囲気下、アセト酢酸メチル(2−
3)0.98g(8.4mmol)、10−ブロモ−1−デ
カノール(2−4)1.0g(4.2mmol)、ジメチル
ホルムアミド3mlを入れ、氷冷下で10分間攪拌し、こ
れに水素化ナトリウム0.37g(8.4mmol)のジメ
チルホルムアミド懸濁溶液5mlを30分かけて滴下し
た。60℃で3時間攪拌した後、放冷し、水15mlを加
え、クロロホルムで抽出を行ったのち、無水硫酸マグネ
シウムで乾燥し、濾別後、減圧濃縮して得られる粗生物
をシリカゲルクロマトグラフィーにて精製して、標記化
合物(2−1)0.77g(収率67%)を得た。
Example 2 30 ml-2 equipped with a reflux condenser and a 10 ml dropping funnel
Methyl acetoacetate (2-
3) 0.98 g (8.4 mmol), 1.0 g (4.2 mmol) of 10-bromo-1-decanol (2-4) and 3 ml of dimethylformamide were added, and the mixture was stirred for 10 minutes under ice-cooling. 5 ml of a suspension of 0.37 g (8.4 mmol) of sodium chloride in dimethylformamide was added dropwise over 30 minutes. After stirring at 60 ° C. for 3 hours, the mixture was allowed to cool, 15 ml of water was added, extracted with chloroform, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to obtain a crude product which was subjected to silica gel chromatography. Then, 0.77 g (yield 67%) of the title compound (2-1) was obtained.

【0034】実施例3 還流冷却管及び10ml−滴下ロート2個を備えた200
ml−3口フラスコに窒素雰囲気下、水素化ナトリウム
(60%)3.61g(90.2mol)、ジメチルホル
ムアミド20mlを入れ、氷冷下、攪拌しながら10−ブ
ロモ−1−デカノール(3−4)5.21g(22.0
mmol)を滴下し、10分間攪拌した後アセト酢酸メチル
(3−3)10.5g(90.4mmol)を30分間かけ
て滴下した。60℃で3時間攪拌した後、放冷し、水1
00mlを加え、クロロホルムで抽出を行ったのち、無水
硫酸マグネシウムで乾燥し、濾別後、減圧濃縮して得ら
れる粗生物をシリカゲルクロマトグラフィーにて精製し
て、標記化合物(3−1)3.24g(収率54%)を
得た。得られた化合物の物性は以下の通りである。
Example 3 200 equipped with a reflux condenser and two 10 ml dropping funnels
Under a nitrogen atmosphere, 3.61 g (90.2 mol) of sodium hydride (60%) and 20 ml of dimethylformamide were placed in a 3-neck flask and stirred under ice cooling with 10-bromo-1-decanol (3-4). ) 5.21 g (22.0
After stirring for 10 minutes, 10.5 g (90.4 mmol) of methyl acetoacetate (3-3) was added dropwise over 30 minutes. After stirring at 60 ° C. for 3 hours, the mixture was allowed to cool,
After addition of 00 ml, extraction with chloroform was performed, followed by drying over anhydrous magnesium sulfate, filtration and concentration under reduced pressure. The resulting crude product was purified by silica gel chromatography to give the title compound (3-1) 3. 24 g (54% yield) were obtained. The physical properties of the obtained compound are as follows.

【0035】性状:淡黄色油状物1 H-NMR(CDCl3,δ) 1.08-1.95(18H,m), 2.22(3H,s), 3.41(1H,t,J=7Hz), 3.
55-3.70(3H,m),3.72(3H,s) IR(NaCl,cm-1) 3432, 2932, 2860, 1744, 1718, 1438, 1362, 1246, 12
06, 1154, 1052.
Properties: pale yellow oil 1 H-NMR (CDCl 3 , δ) 1.08-1.95 (18H, m), 2.22 (3H, s), 3.41 (1H, t, J = 7 Hz), 3.
55-3.70 (3H, m), 3.72 (3H, s) IR (NaCl, cm -1 ) 3432, 2932, 2860, 1744, 1718, 1438, 1362, 1246, 12
06, 1154, 1052.

【0036】実施例4 13−ヒドロキシ−2−トリ
デカノン(4−2)の製造
Example 4 Preparation of 13-hydroxy-2-tridecanone (4-2)

【0037】[0037]

【化9】 Embedded image

【0038】還流冷却管を備えた30ml−2口フラスコ
に2−アセチル−12−ヒドロキシドデカン酸メチル
(4−1)0.62g(2.3mmol)、水酸化ナトリウ
ム0.28g(6.9mmol)、エタノール:水=1:1
溶液5mlを入れ、80℃で2時間攪拌した。反応溶液を
室温まで冷却した後、50%H2SO4水溶液0.76g
(3.8mmol)をゆっくり加えるとガスが発生した。発
泡がおさまってから80℃で30分間攪拌した後、放冷
し、水20mlを加え、酢酸エチルで抽出を行った。有機
層を飽和炭酸水素ナトリウム水溶液、続いて飽和食塩水
で洗浄した後、無水硫酸マグネシウムで乾燥し、濾別
後、減圧濃縮して得られる粗生成物をシリカゲルクロマ
トグラフィーにて精製し、標記化合物(4−2)0.4
4g(収率89%)を得た。得られた化合物の物性は以
下の通りである。
In a 30 ml two-necked flask equipped with a reflux condenser, 0.62 g (2.3 mmol) of methyl 2-acetyl-12-hydroxydodecanoate (4-1) and 0.28 g (6.9 mmol) of sodium hydroxide were added. , Ethanol: water = 1: 1
5 ml of the solution was added and stirred at 80 ° C. for 2 hours. After cooling the reaction solution to room temperature, 0.76 g of 50% H 2 SO 4 aqueous solution
(3.8 mmol) was added slowly to generate gas. After the foaming had ceased, the mixture was stirred at 80 ° C. for 30 minutes, allowed to cool, added with 20 ml of water, and extracted with ethyl acetate. The organic layer was washed with a saturated aqueous solution of sodium hydrogencarbonate and subsequently with a saturated saline solution, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure, and the crude product obtained was purified by silica gel chromatography to give the title compound (4-2) 0.4
4 g (89% yield) were obtained. The physical properties of the obtained compound are as follows.

【0039】1H-NMR(CDCl3,δ) 1.16-1.70(19H,m), 2.13(3H,s), 2.41(2H,t,J=7Hz), 3.
63(2H,t,J=6Hz) IR(KBr,cm-1) 3360, 2924, 2856, 1706, 1472, 1380, 1064.
1 H-NMR (CDCl 3 , δ) 1.16-1.70 (19H, m), 2.13 (3H, s), 2.41 (2H, t, J = 7 Hz), 3.
63 (2H, t, J = 6Hz) IR (KBr, cm -1 ) 3360, 2924, 2856, 1706, 1472, 1380, 1064.

【0040】実施例5 13−ベンジルオキシ−2−
トリデカノン(5−2)の製造
Example 5 13-benzyloxy-2-
Production of Tridecanone (5-2)

【0041】[0041]

【化10】 Embedded image

【0042】10−クロロ−1−ベンジルオキシデカン
(5−4)の製造
Preparation of 10-chloro-1-benzyloxydecane (5-4)

【0043】[0043]

【化11】 Embedded image

【0044】300ml−滴下ロート、還流冷却管、メカ
ニカルスターラーを備えた3口1000ml−フラスコに
1,10−デカンジオール320.0g(1.84mo
l)、キシレン1600ml、硫酸3.2g(32mmol)
を入れ、攪拌しながら82〜87℃に加熱した。塩酸
(36%)1468.9g(15mol)を3時間かけて
滴下後、同条件下14時間さらに加熱・攪拌した。室温
まで冷却後、静置し、下層を廃棄した。水、炭酸水素ナ
トリウム水溶液、水にて順次洗浄した後、減圧濃縮して
粗生物361.8gを得た。次に500ml−滴下ロー
ト、還流冷却管、メカニカルスターラーを備えた3口3
Lフラスコにベンジルクロライド475.4g(3.7
5mol)、48%水酸化ナトリウム水溶液470.0g
(5.6mol)、テトラ−n−ブチルアンモニウムブロ
マイド1.9g(5.9mmol)を入れ、攪拌しながら前
工程の粗生物361.8gを30分かけて滴下したの
ち、12時間、30〜35℃に加熱した。水及びヘキサ
ンを加え、下層廃棄後、飽和食塩水にて洗浄し、硫酸マ
グネシウムを加え乾燥した。ろ過後、減圧濃縮して粗生
物523.8gを得た。これを蒸留精製することによ
り、標記化合物(5−4)450g(収率86%)を得
た。得られた化合物の物性は以下の通りである。
In a 3-neck 1000 ml flask equipped with a 300 ml-dropping funnel, a reflux condenser, and a mechanical stirrer, 320.0 g (1.84 mol) of 1,10-decanediol was added.
l), xylene 1600 ml, sulfuric acid 3.2 g (32 mmol)
And heated to 82-87 ° C. with stirring. After 1468.9 g (15 mol) of hydrochloric acid (36%) was added dropwise over 3 hours, the mixture was further heated and stirred for 14 hours under the same conditions. After cooling to room temperature, it was left still and the lower layer was discarded. After sequentially washing with water, an aqueous solution of sodium hydrogen carbonate and water, the solution was concentrated under reduced pressure to obtain 361.8 g of a crude product. Next, 500 ml-3 ports 3 equipped with a dropping funnel, a reflux condenser, and a mechanical stirrer
475.4 g (3.7) of benzyl chloride was placed in an L flask.
5 mol), 470.0 g of a 48% aqueous sodium hydroxide solution
(5.6 mol) and 1.9 g (5.9 mmol) of tetra-n-butylammonium bromide were added, and 361.8 g of the crude product from the previous step was added dropwise with stirring over 30 minutes, and then 30 to 35 for 12 hours. Heated to ° C. Water and hexane were added, and the lower layer was discarded, washed with saturated saline, dried over magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure to obtain 523.8 g of a crude product. This was purified by distillation to obtain 450 g (yield 86%) of the title compound (5-4). The physical properties of the obtained compound are as follows.

【0045】性状:無色油状物1 H-NMR(CDCl3,δ) 1.20-1.86(16H,m), 3.54(2H,t,J=6.7Hz), 3.53(2H,t,J=
6.7Hz),4.50(2H,s), 7.20-7.38(5H,m) IR(NaCl, cm-1) 2932, 2860, 1456, 1104, 734, 696.
Properties: colorless oil 1 H-NMR (CDCl 3 , δ) 1.20-1.86 (16H, m), 3.54 (2H, t, J = 6.7 Hz), 3.53 (2H, t, J =
6.7Hz), 4.50 (2H, s), 7.20-7.38 (5H, m) IR (NaCl, cm- 1 ) 2932, 2860, 1456, 1104, 734, 696.

【0046】2−アセチル−12−ベンジルオキシドデ
カン酸メチル(5−1)の製造
Preparation of methyl 2-acetyl-12-benzyloxidedecanoate (5-1)

【0047】[0047]

【化12】 Embedded image

【0048】還流冷却管、メカニカルスターラーを備え
た3口2Lフラスコに10−クロロ−1−ベンジルオキ
シデカン(5−4)318.0g(1.12mol)、ア
セト酢酸メチル(5−3)246.3g(2.12mo
l)、炭酸カリウム161.3g(1.17mol)、ヨウ
化カリウム35.3g(0.21mol)、N,N−ジメ
チルホルムアミド318.0gを入れ、攪拌しながら7
5〜80℃に加熱した。10時間後、室温まで冷却し、
水318gを加え、トルエンにて抽出した。飽和食塩水
で洗浄後、硫酸マグネシウムで乾燥し、ろ過して減圧濃
縮した。得られた粗生物をシリカゲルカラムにて精製
し、標記化合物(5−1)277.2g(収率68%)
を得た。得られた化合物の物性は以下の通りである。
In a 3-neck 2 L flask equipped with a reflux condenser and a mechanical stirrer, 318.0 g (1.12 mol) of 10-chloro-1-benzyloxydecane (5-4) and methyl acetoacetate (5-3) 246. 3g (2.12mo
l), 161.3 g (1.17 mol) of potassium carbonate, 35.3 g (0.21 mol) of potassium iodide, and 318.0 g of N, N-dimethylformamide were added thereto, and stirred.
Heated to 5-80 ° C. After 10 hours, cool to room temperature,
318 g of water was added and extracted with toluene. After washing with a saturated saline solution, it was dried over magnesium sulfate, filtered and concentrated under reduced pressure. The obtained crude product was purified by a silica gel column, and 277.2 g of the title compound (5-1) (68% yield).
I got The physical properties of the obtained compound are as follows.

【0049】性状:無色油状物1 H-NMR(CDCl3,δ) 1.12-1.95(18H,m), 2.22(3H,s), 3.35-3.51(3H,m), 3.7
2(3H,s),4.50(2H,s), 7.18-7.38(5H,m) IR(NaCl, cm-1) 2932, 2860, 1746, 1720, 1456, 1360, 1244, 1204, 11
44, 734, 698.
Properties: colorless oil 1 H-NMR (CDCl 3 , δ) 1.12-1.95 (18H, m), 2.22 (3H, s), 3.35-3.51 (3H, m), 3.7
2 (3H, s), 4.50 (2H, s), 7.18-7.38 (5H, m) IR (NaCl, cm -1 ) 2932, 2860, 1746, 1720, 1456, 1360, 1244, 1204, 11
44, 734, 698.

【0050】13−ベンジルオキシ−2−トリデカノン
(5−2)の製造 還流冷却管、メカニカルスターラーを備えた3口2Lフ
ラスコに2−アセチル−12−ベンジルオキシドデカン
酸メチル(5−1)200.0g(0.55mol)、1
0%NaOH水溶液242.8gを加え、室温下14時
間攪拌した。次に50%H2SO4 水溶液65.4gを
加え、45〜50℃に加熱した。1時間後、室温まで冷
却し、水318gを加え、トルエンにて抽出を行った。
飽和食塩水にて洗浄した後、減圧濃縮して得られるクル
ードをシリカゲルカラムにより精製して標記化合物(5
−2)131.0g(収率78%)を得た。得られた化
合物の物性は以下の通りである。
Preparation of 13-benzyloxy-2-tridecanone (5-2) In a 3-neck 2 L flask equipped with a reflux condenser and a mechanical stirrer, methyl 2-acetyl-12-benzyloxidedecanoate (5-1) was prepared. 0 g (0.55 mol), 1
242.8 g of a 0% NaOH aqueous solution was added, and the mixture was stirred at room temperature for 14 hours. Next, 65.4 g of a 50% H 2 SO 4 aqueous solution was added, and the mixture was heated to 45 to 50 ° C. One hour later, the mixture was cooled to room temperature, added with 318 g of water, and extracted with toluene.
After washing with a saturated saline solution, the crude obtained by concentration under reduced pressure was purified by a silica gel column to give the title compound (5
-2) 131.0 g (78% yield) was obtained. The physical properties of the obtained compound are as follows.

【0051】性状:無色油状物1 H-NMR(CDCl3,δ) 1.20-1.70(18H,m), 2.13(3H,s), 2.41(2H,t,J=7.3Hz),
3.46(2H,t,J=6.6Hz), 4.50(2H,s), 7.20-7.38(5H,m) IR(NaCl, cm-1) 2932, 2860, 1720, 1456, 1362, 1102, 734, 696.
Properties: colorless oil 1 H-NMR (CDCl 3 , δ) 1.20-1.70 (18H, m), 2.13 (3H, s), 2.41 (2H, t, J = 7.3 Hz),
3.46 (2H, t, J = 6.6Hz), 4.50 (2H, s), 7.20-7.38 (5H, m) IR (NaCl, cm -1 ) 2932, 2860, 1720, 1456, 1362, 1102, 734, 696 .

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI C07C 49/213 C07C 49/213 69/716 69/716 Z (72)発明者 藤倉 芳明 栃木県芳賀郡市貝町赤羽2606 花王株式会 社研究所内────────────────────────────────────────────────── ─── Continued on the front page (51) Int.Cl. 6 Identification symbol FI C07C 49/213 C07C 49/213 69/716 69/716 Z (72) Inventor Yoshiaki Fujikura 2606 Kabanecho, Kaga-cho, Haga-gun, Tochigi Pref. Inside the company research laboratory

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 次の一般式(1) 【化1】 〔式中、R1 は水素原子又はベンジル基を示し、R2
低級アルキル基を示し、nは8〜12の整数を示す〕で
表わされる2−アセチルカルボン酸エステル誘導体。
1. The following general formula (1): [Wherein, R 1 represents a hydrogen atom or a benzyl group, R 2 represents a lower alkyl group, and n represents an integer of 8 to 12].
【請求項2】 請求項1記載の2−アセチルカルボン酸
エステル誘導体を加水分解及び脱炭酸することを特徴と
する次の一般式(2) 【化2】 〔式中、R1 及びnは前記と同じものを示す〕で表わさ
れる2−ケトン類の製造法。
2. The following general formula (2) wherein the 2-acetyl carboxylic acid ester derivative according to claim 1 is hydrolyzed and decarboxylated. [Wherein R 1 and n are the same as those described above].
JP22779897A 1996-09-06 1997-08-25 2-acetyl carboxylic acid ester derivative and production of 2-ketone compounds from the same Pending JPH10130191A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22779897A JPH10130191A (en) 1996-09-06 1997-08-25 2-acetyl carboxylic acid ester derivative and production of 2-ketone compounds from the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23643296 1996-09-06
JP8-236432 1996-09-06
JP22779897A JPH10130191A (en) 1996-09-06 1997-08-25 2-acetyl carboxylic acid ester derivative and production of 2-ketone compounds from the same

Publications (1)

Publication Number Publication Date
JPH10130191A true JPH10130191A (en) 1998-05-19

Family

ID=26527870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22779897A Pending JPH10130191A (en) 1996-09-06 1997-08-25 2-acetyl carboxylic acid ester derivative and production of 2-ketone compounds from the same

Country Status (1)

Country Link
JP (1) JPH10130191A (en)

Similar Documents

Publication Publication Date Title
FR2658513A1 (en) PROCESS FOR THE PREPARATION OF CIS-BETA-PHENYLGLYCIDIC- (2R, 3R) ACID.
FI91394C (en) Esters and amides of eicosatryynoic acid and their use in cosmetology
JPH03109384A (en) Production of (s)-4-hydroxymethyl-gamma-lactone
JPH10130191A (en) 2-acetyl carboxylic acid ester derivative and production of 2-ketone compounds from the same
EP0002408A1 (en) Substituted phenoxyalkanols, their preparation and their use as therapeutic agents
AU606111B2 (en) Eicosatetraynoic acid amides and their application in pharmacy and in cosmetics
JP4210573B2 (en) Substituted phenoxypropanolamines
Youn et al. Highly diastereoselective additions of methoxyallene and acetylenes to chiral α-keto amidesElectronic supplementary information (ESI) available: synthesis and spectroscopic data for 4b, 5g, 6b and 7b. See http://www. rsc. org/suppdata/cc/b1/b100355k
CA1257289A (en) 1-substituted 4-methoxy-2,3,6-trimethylbenzene derivatives; process for preparing the same and their use as cosmetics
JP2004161702A (en) METHOD FOR PRODUCING gamma-JASMOLACTONE
JP3731913B2 (en) Process for producing cis-1-aminoindan-2-ol
DK170399B1 (en) Naphthalene derivatives of the benzonorborn, process for their preparation and pharmaceuticals and cosmetics containing such compounds
JP3338227B2 (en) Method for producing ketonitrile derivative and hexenone derivative
Csákÿ et al. Asymmetric CC bond formation by the mixed oxidative coupling of 1, 1′-bi-2-naphthyl esters
JP4159700B2 (en) Cyclohexylmethanol
JPH072678B2 (en) Process for producing 2-cyclopentenone derivative
FR2494584A1 (en) MEDICINES CONSISTING OF NEW 2-AMINOETHANOLS AND THEIR MANUFACTURING PROCESS
JP2804654B2 (en) Method for producing (S)-(-)-dehydro-α-damaschol
JP3272340B2 (en) Method for producing 1-[(cyclopent-3-en-1-yl) methyl] -5-ethyl-6- (3,5-dimethylbenzoyl) -2,4-pyrimidinedione
FR2724652A1 (en) USE OF DEHYDROALANINE DERIVATIVES FOR PROTECTING SKIN, MUCOSES AND / OR HAIR FROM OXIDIZING STRESS.
JP2003113189A (en) Method for producing cyclopentabenzofuran derivative and novel compound to be raw material of the same
CH680733A5 (en)
JPH09323955A (en) Benzoic derivative and medicine containing the same
KR100343551B1 (en) Process for preparing 4-alkoxycarbonyl-5-chloropyrazole derivatives
KR100365526B1 (en) Synthesis of the bicyclo[3.3.1]nonane structure